Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer
Author(s) -
Soo Hyun Lee,
Kyunghee Park,
Gun Min Kim,
Kyung Hae Jung,
Seok Yun Kang,
In Hae Park,
Jee Hyun Kim,
Hee Kyung Ahn,
WoongYang Park,
SeockAh Im,
Yeon Hee Park
Publication year - 2022
Publication title -
the breast
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.563
H-Index - 78
eISSN - 1532-3080
pISSN - 0960-9776
DOI - 10.1016/j.breast.2022.01.014
Subject(s) - palbociclib , medicine , oncology , breast cancer , capecitabine , hazard ratio , cancer , pten , metastatic breast cancer , confidence interval , colorectal cancer , pi3k/akt/mtor pathway , genetics , biology , apoptosis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom